Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-064594
Filing Date
2025-05-06
Accepted
2025-05-06 17:01:57
Documents
64
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bcab-20250331.htm   iXBRL 10-Q 1824153
2 EX-31.1 bcab-ex31_1.htm EX-31.1 17305
3 EX-31.2 bcab-ex31_2.htm EX-31.2 17257
4 EX-32.1 bcab-ex32_1.htm EX-32.1 16060
  Complete submission text file 0000950170-25-064594.txt   7134918

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bcab-20250331.xsd EX-101.SCH 1052411
67 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20250331_htm.xml XML 1144072
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

EIN.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39787 | Film No.: 25918160
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)